Hospira Vinorelbine Tartrate10 mg/1 mL Injection Vial

Country: Ástralía

Tungumál: enska

Heimild: Department of Health (Therapeutic Goods Administration)

Virkt innihaldsefni:

vinorelbine tartrate, Quantity: 13.85 mg/mL (Equivalent: vinorelbine, Qty 10 mg/mL)

Fáanlegur frá:

Hospira Australia Pty Ltd

INN (Alþjóðlegt nafn):

Vinorelbine tartrate

Lyfjaform:

Injection

Samsetning:

Excipient Ingredients: water for injections

Stjórnsýsluleið:

Intravenous

Einingar í pakka:

1 x 1 mL vial

Tegund:

Medicine Listed (Export Only)

Gerð lyfseðils:

Not scheduled. Not considered by committee

Ábendingar:

Vinorelbine is indicated as a single agent or in combination with cisplatin for the first-line treatment of ambulatory patients with unresectable, advanced nonsmall cell lung cancer (NSCLC). In patients with stage IV NSCLC, Vinorelbine is indicated as a single agent or in combination with cisplatin. In stage III NSCLC, Vinorelbine is indicated with in combination with cisplatin.

Vörulýsing:

Visual Identification: A clear, colourless to pale yellow solution & free from visible particulates; Container Type: Vial; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Leyfisstaða:

Listed (Export Only)

Leyfisdagur:

2008-05-05